What is the most likely diagnosis for an adult patient with a history of diabetes mellitus (DM) presenting with hyperglycemia, a Hemoglobin A1c (HbA1c) level of 13.1, and elevated glucose and insulin levels?

Type 2 Diabetes Mellitus with Severe Hyperglycemia and Preserved Insulin Secretion

The most likely diagnosis is Type 2 Diabetes Mellitus (T2DM) with severe, uncontrolled hyperglycemia, as evidenced by the markedly elevated HbA1c of 13.1% (diagnostic threshold ≥6.5%), glucose of 550 mg/dL, and critically, the preserved endogenous insulin production demonstrated by elevated insulin (14.3) and C-peptide (3.9) levels. 1, 2

Diagnostic Reasoning

Confirming Diabetes Mellitus

• HbA1c of 13.1% definitively establishes diabetes, far exceeding the diagnostic threshold of ≥6.5% and indicating severely poor glycemic control over the preceding 8-12 weeks 1
• Glucose of 550 mg/dL (30.5 mmol/L) confirms severe hyperglycemia, well above the diagnostic criterion of ≥200 mg/dL (11.1 mmol/L) 1, 2

Distinguishing Type 2 from Type 1 Diabetes

The preserved C-peptide (3.9) and elevated insulin (14.3) are the critical discriminating factors:

• Type 2 diabetes is characterized by insulin resistance with preserved or even elevated insulin production that is inadequate relative to the degree of insulin resistance 2
• Type 1 diabetes results from autoimmune β-cell destruction leading to insulinopenia (absolute insulin deficiency), which would manifest as low or undetectable C-peptide and insulin levels 1, 2, 3
• The presence of measurable—and in this case elevated—C-peptide definitively indicates preserved pancreatic β-cell function, ruling out Type 1 diabetes 2, 3

Understanding the Elevated Insulin and C-peptide

• In T2DM, peripheral tissues develop insulin resistance, requiring higher insulin levels to achieve glucose uptake 2
• The pancreas initially compensates by producing more insulin (hyperinsulinemia), but this production is disproportionately low for the degree of insulin resistance present 2
• The elevated insulin and C-peptide in the setting of severe hyperglycemia indicate that insulin production, while present, is insufficient to overcome the insulin resistance 2

Clinical Context and Severity Assessment

Assessing for Hyperglycemic Crisis

This patient requires immediate evaluation for hyperosmolar hyperglycemic state (HHS):

• HHS typically presents with severe hyperglycemia >600 mg/dL (this patient is at 550 mg/dL), effective osmolality >320 mOsm/L, minimal ketones, pH >7.30, and bicarbonate >18 mEq/L 4
• HHS occurs predominantly in Type 2 diabetes and is characterized by profound dehydration without significant ketoacidosis 4
• Immediate testing should include: serum electrolytes with calculated anion gap, serum osmolality, arterial blood gases, blood urea nitrogen/creatinine, serum and urine ketones, complete blood count, and electrocardiogram 4
• Calculate effective osmolality: 2[Na] + glucose/18 to determine if HHS criteria are met (>320 mOsm/L) 4

Distinguishing from Stress Hyperglycemia

• Stress hyperglycemia would present with HbA1c <6.5% despite elevated acute glucose, as HbA1c reflects 8-12 weeks of glycemic control 1
• This patient's HbA1c of 13.1% indicates chronic, severe hyperglycemia, not acute stress-induced elevation 1

Immediate Management Priorities

Fluid Resuscitation

• Initiate isotonic saline 15-20 mL/kg/h in the first hour (1-1.5 liters in average adult) if HHS is confirmed, as volume depletion and dehydration are life-threatening 4

Insulin Therapy

• Intravenous insulin infusion provides rapid-acting control of severe hyperglycemia 4
• Monitor potassium levels closely as IV insulin drives potassium intracellularly, risking life-threatening hypokalemia 4, 5
• Add 20-30 mEq/L potassium to fluids once adequate renal function is confirmed 4

Infection Screening

• Obtain bacterial cultures of urine, blood, and throat as infection is the most common precipitating factor for hyperglycemic crises 4

Common Pitfalls to Avoid

• Do not assume Type 1 diabetes based solely on severe hyperglycemia—the presence of C-peptide and insulin distinguishes T2DM from T1DM 2, 3
• Do not delay fluid resuscitation while awaiting laboratory confirmation of HHS, as dehydration contributes significantly to morbidity and mortality 4
• Do not overlook hypokalemia risk when initiating insulin therapy, as this can cause respiratory paralysis, ventricular arrhythmia, and death 4, 5
• Do not attribute the hyperglycemia to stress alone when HbA1c is markedly elevated, as this indicates chronic poor control requiring long-term diabetes management 1